217 related articles for article (PubMed ID: 18359633)
1. Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.
Starck JP; Provins L; Christophe B; Gillard M; Jadot S; Lo Brutto P; Quéré L; Talaga P; Guyaux M
Bioorg Med Chem Lett; 2008 Apr; 18(8):2675-8. PubMed ID: 18359633
[TBL] [Abstract][Full Text] [Related]
2. The discovery of AZD9164, a novel muscarinic M3 antagonist.
Mete A; Bowers K; Chevalier E; Donald DK; Edwards H; Escott KJ; Ford R; Grime K; Millichip I; Teobald B; Russell V
Bioorg Med Chem Lett; 2011 Dec; 21(24):7440-6. PubMed ID: 22047691
[TBL] [Abstract][Full Text] [Related]
3. Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.
Starck JP; Talaga P; Quéré L; Collart P; Christophe B; Lo Brutto P; Jadot S; Chimmanamada D; Zanda M; Wagner A; Mioskowski C; Massingham R; Guyaux M
Bioorg Med Chem Lett; 2006 Jan; 16(2):373-7. PubMed ID: 16275087
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).
Prat M; Fernández D; Buil MA; Crespo MI; Casals G; Ferrer M; Tort L; Castro J; Monleón JM; Gavaldà A; Miralpeix M; Ramos I; Doménech T; Vilella D; Antón F; Huerta JM; Espinosa S; López M; Sentellas S; González M; Albertí J; Segarra V; Cárdenas A; Beleta J; Ryder H
J Med Chem; 2009 Aug; 52(16):5076-92. PubMed ID: 19653626
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
[TBL] [Abstract][Full Text] [Related]
6. First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.
Provins L; Christophe B; Danhaive P; Dulieu J; Durieu V; Gillard M; Lebon F; Lengelé S; Quéré L; van Keulen B
Bioorg Med Chem Lett; 2006 Apr; 16(7):1834-9. PubMed ID: 16439121
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.
Prat M; Buil MA; Fernández MD; Castro J; Monleón JM; Tort L; Casals G; Ferrer M; Huerta JM; Espinosa S; López M; Segarra V; Gavaldà A; Miralpeix M; Ramos I; Vilella D; González M; Córdoba M; Cárdenas A; Antón F; Beleta J; Ryder H
Bioorg Med Chem Lett; 2011 Jun; 21(11):3457-61. PubMed ID: 21524581
[TBL] [Abstract][Full Text] [Related]
8. 3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists.
Nordvall G; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U
J Med Chem; 1996 Aug; 39(17):3269-77. PubMed ID: 8765510
[TBL] [Abstract][Full Text] [Related]
9. Isopropyl amide derivatives of potent and selective muscarinic M2 receptor antagonists.
Palani A; Dugar S; Clader JW; Greenlee WJ; Ruperto V; Duffy RA; Lachowicz JE
Bioorg Med Chem Lett; 2004 Apr; 14(7):1791-4. PubMed ID: 15026073
[TBL] [Abstract][Full Text] [Related]
10. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.
Lainé DI; McCleland B; Thomas S; Neipp C; Underwood B; Dufour J; Widdowson KL; Palovich MR; Blaney FE; Foley JJ; Webb EF; Luttmann MA; Burman M; Belmonte K; Salmon M
J Med Chem; 2009 Apr; 52(8):2493-505. PubMed ID: 19317446
[TBL] [Abstract][Full Text] [Related]
12. 3-Heteroarylquinuclidin-2-ene derivatives as muscarinic antagonists: synthesis, structure-activity relationships and molecular modelling.
Nordvall G; Nilsson BM; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U
Prog Brain Res; 1996; 109():141-5. PubMed ID: 9009700
[No Abstract] [Full Text] [Related]
13. The effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3α-acyloxy-6β-acetoxyltropane derivatives as muscarinic M3 receptor antagonists.
Wang ZP; Liu HZ; Zhu L; Hu YM; Cui YY; Niu YY; Lu Y; Chen HZ
Bioorg Med Chem; 2013 Mar; 21(5):1234-9. PubMed ID: 23375092
[TBL] [Abstract][Full Text] [Related]
14. Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments.
Del Bello F; Bonifazi A; Giorgioni G; Petrelli R; Quaglia W; Altomare A; Falcicchio A; Matucci R; Vistoli G; Piergentili A
Eur J Med Chem; 2017 Sep; 137():327-337. PubMed ID: 28609709
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.
Prat M; Buil MA; Fernández MD; Tort L; Monleón JM; Casals G; Ferrer M; Castro J; Gavaldà A; Miralpeix M; Ramos I; Vilella D; Huerta JM; Espinosa S; Hernández B; Segarra V; Córdoba M
Bioorg Med Chem Lett; 2015 Apr; 25(8):1736-1741. PubMed ID: 25800115
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonists.
Kumar N; Kaur K; Aeron S; Dharmarajan S; Silamkoti AD; Mehta A; Gupta S; Chugh A; Gupta JB; Salman M; Palle VP; Cliffe IA
Bioorg Med Chem Lett; 2007 Sep; 17(18):5256-60. PubMed ID: 17629699
[TBL] [Abstract][Full Text] [Related]
17. Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists.
Nagashima S; Matsushima Y; Hamaguchi H; Nagata H; Kontani T; Moritomo A; Koshika T; Takeuchi M
Bioorg Med Chem; 2014 Jul; 22(13):3478-87. PubMed ID: 24837158
[TBL] [Abstract][Full Text] [Related]
18. Multivalent dual pharmacology muscarinic antagonist and β₂ agonist (MABA) molecules for the treatment of COPD.
Hughes AD; McNamara A; Steinfeld T
Prog Med Chem; 2012; 51():71-95. PubMed ID: 22520472
[No Abstract] [Full Text] [Related]
19. Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice.
Ito Y; Oyunzul L; Yoshida A; Fujino T; Noguchi Y; Yuyama H; Ohtake A; Suzuki M; Sasamata M; Matsui M; Yamada S
Eur J Pharmacol; 2009 Aug; 615(1-3):201-6. PubMed ID: 19446545
[TBL] [Abstract][Full Text] [Related]
20. Efficient conversion of a nonselective norepinephrin reuptake inhibitor into a dual muscarinic antagonist-β₂-agonist for the treatment of chronic obstructive pulmonary disease.
Osborne R; Clarke N; Glossop P; Kenyon A; Liu H; Patel S; Summerhill S; Jones LH
J Med Chem; 2011 Oct; 54(19):6998-7002. PubMed ID: 21863888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
